KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Novavax (NVAX) Net Margin (2016 - 2025)

Novavax (NVAX) has 16 years of Net Margin data on record, last reported at 11.91% in Q4 2025.

  • For Q4 2025, Net Margin rose 10367.0% year-over-year to 11.91%; the TTM value through Dec 2025 reached 41.57%, up 6905.0%, while the annual FY2025 figure was 39.19%, 6668.0% up from the prior year.
  • Net Margin reached 11.91% in Q4 2025 per NVAX's latest filing, up from 287.29% in the prior quarter.
  • Across five years, Net Margin topped out at 77.8% in Q1 2025 and bottomed at 380.87% in Q4 2021.
  • Average Net Margin over 5 years is 100.97%, with a median of 65.58% recorded in 2023.
  • Peak YoY movement for Net Margin: skyrocketed 71609bps in 2021, then crashed -39196bps in 2023.
  • A 5-year view of Net Margin shows it stood at 380.87% in 2021, then soared by 87bps to 50.99% in 2022, then dropped by -20bps to 61.23% in 2023, then crashed by -50bps to 91.76% in 2024, then soared by 113bps to 11.91% in 2025.
  • Per Business Quant database, its latest 3 readings for Net Margin were 11.91% in Q4 2025, 287.29% in Q3 2025, and 60.86% in Q2 2025.